FR2759293B1 - Microgranules contenant du cisplatine, procede de fabrication, preparation pharmaceutique et utilisation en polychimiotherapie ou en association avec une radiotherapie - Google Patents

Microgranules contenant du cisplatine, procede de fabrication, preparation pharmaceutique et utilisation en polychimiotherapie ou en association avec une radiotherapie

Info

Publication number
FR2759293B1
FR2759293B1 FR9701545A FR9701545A FR2759293B1 FR 2759293 B1 FR2759293 B1 FR 2759293B1 FR 9701545 A FR9701545 A FR 9701545A FR 9701545 A FR9701545 A FR 9701545A FR 2759293 B1 FR2759293 B1 FR 2759293B1
Authority
FR
France
Prior art keywords
polychemotherapy
radiotherapy
cisplatin
association
manufacturing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9701545A
Other languages
English (en)
French (fr)
Other versions
FR2759293A1 (fr
Inventor
Patrice Debregeas
Gerard Leduc
Pascal Oury
Pascal Suplie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ethypharm SAS
Original Assignee
Ethypharm SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9701545A priority Critical patent/FR2759293B1/fr
Application filed by Ethypharm SAS filed Critical Ethypharm SAS
Priority to PT98908157T priority patent/PT971702E/pt
Priority to US09/367,270 priority patent/US6458389B1/en
Priority to AT98908157T priority patent/ATE255409T1/de
Priority to BR9807319-2A priority patent/BR9807319A/pt
Priority to AU66267/98A priority patent/AU744001C/en
Priority to NZ337216A priority patent/NZ337216A/xx
Priority to DE69820239T priority patent/DE69820239T2/de
Priority to HU0001719A priority patent/HU225425B1/hu
Priority to EP98908157A priority patent/EP0971702B1/fr
Priority to JP53389798A priority patent/JP4549445B2/ja
Priority to IN337DE1998 priority patent/IN187998B/en
Priority to TW087101722A priority patent/TW561055B/zh
Priority to PL335107A priority patent/PL191631B1/pl
Priority to DK98908157T priority patent/DK0971702T3/da
Priority to PCT/FR1998/000251 priority patent/WO1998034599A1/fr
Priority to ES98908157T priority patent/ES2210726T3/es
Priority to CA002282082A priority patent/CA2282082C/fr
Priority to EA199900734A priority patent/EA001760B1/ru
Priority to IL13132698A priority patent/IL131326A/xx
Priority to KR10-1999-7007263A priority patent/KR100471672B1/ko
Priority to ARP980100613A priority patent/AR011133A1/es
Priority to ZA981123A priority patent/ZA981123B/xx
Publication of FR2759293A1 publication Critical patent/FR2759293A1/fr
Application granted granted Critical
Publication of FR2759293B1 publication Critical patent/FR2759293B1/fr
Priority to BG103647A priority patent/BG64247B1/bg
Priority to NO19993881A priority patent/NO323230B1/no
Priority to US10/200,998 priority patent/US20030017210A1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR9701545A 1997-02-11 1997-02-11 Microgranules contenant du cisplatine, procede de fabrication, preparation pharmaceutique et utilisation en polychimiotherapie ou en association avec une radiotherapie Expired - Lifetime FR2759293B1 (fr)

Priority Applications (26)

Application Number Priority Date Filing Date Title
FR9701545A FR2759293B1 (fr) 1997-02-11 1997-02-11 Microgranules contenant du cisplatine, procede de fabrication, preparation pharmaceutique et utilisation en polychimiotherapie ou en association avec une radiotherapie
PCT/FR1998/000251 WO1998034599A1 (fr) 1997-02-11 1998-02-10 Microgranules contenant du cisplatine
AT98908157T ATE255409T1 (de) 1997-02-11 1998-02-10 Cisplatinhaltige mikrogranulate
BR9807319-2A BR9807319A (pt) 1997-02-11 1998-02-10 Microgrânulos com liberação controlada, para administração oral, contendo cisplatina, processo de preparação dos mesmos, preparação farmacêutica, e, utilização dos microgrânulos.
AU66267/98A AU744001C (en) 1997-02-11 1998-02-10 Microgranules containing cisplatin
NZ337216A NZ337216A (en) 1997-02-11 1998-02-10 controlled-release microgranules containing cisplatin having a mean particle size of 0.4-1.5mm
DE69820239T DE69820239T2 (de) 1997-02-11 1998-02-10 Cisplatinhaltige mikrogranulate
HU0001719A HU225425B1 (en) 1997-02-11 1998-02-10 Microgranules containing cisplatin
EP98908157A EP0971702B1 (fr) 1997-02-11 1998-02-10 Microgranules contenant du cisplatine
JP53389798A JP4549445B2 (ja) 1997-02-11 1998-02-10 シスプラチン含有マイクロ顆粒
IN337DE1998 IN187998B (enExample) 1997-02-11 1998-02-10
TW087101722A TW561055B (en) 1997-02-11 1998-02-10 Microgranules containing cisplatin and it's pharmaceutical preparation
PL335107A PL191631B1 (pl) 1997-02-11 1998-02-10 Mikrogranulki o kontrolowanym uwalnianiu do podawania doustnego, sposób ich wytwarzania, preparat farmaceutyczny je zawierający oraz ich zastosowanie
DK98908157T DK0971702T3 (da) 1997-02-11 1998-02-10 Mikrogranula indeholdende cisplatin
PT98908157T PT971702E (pt) 1997-02-11 1998-02-10 Microgranulos contendo cis-platina
CA002282082A CA2282082C (fr) 1997-02-11 1998-02-10 Microgranules contenant du cisplatine
ES98908157T ES2210726T3 (es) 1997-02-11 1998-02-10 Microgranulos que contienen cisplatina.
EA199900734A EA001760B1 (ru) 1997-02-11 1998-02-10 Микрокапсулы, содержащие цис-платину
IL13132698A IL131326A (en) 1997-02-11 1998-02-10 Microgranules containing cisplatin
KR10-1999-7007263A KR100471672B1 (ko) 1997-02-11 1998-02-10 시스플라틴을 함유하는 마이크로그래뉼
US09/367,270 US6458389B1 (en) 1997-02-11 1998-02-10 Microgranules containing cisplatin
ZA981123A ZA981123B (en) 1997-02-11 1998-02-11 Microgranules containing cisplastin manufacturing process pharmaceutical preparation and use in polychemotherapy or in combination with a radiotherapy
ARP980100613A AR011133A1 (es) 1997-02-11 1998-02-11 MICROGRÁNULOS DE LIBERACIoN CONTROLADA QUE CONTIENEN CISPLATINO , PROCEDIMIENTO DE SU PREPARACIoN, COMPOSICIoN FARMACÉUTICA Y UTILIZACIoN EN LA FABRICACIoN DE UN MEDICAMENTO POLIQUIMIOTERAPIA O EN ASOCIACIoN CON UNA RADIOTERAPIA.
BG103647A BG64247B1 (bg) 1997-02-11 1999-08-10 Микрогранули, съдържащи цисплатина
NO19993881A NO323230B1 (no) 1997-02-11 1999-08-11 Mikrogranulater for kontrollert frigjoring for oral administrering som inneholder cisplatin, farmasoytiske preparater derav og anvendelse derav.
US10/200,998 US20030017210A1 (en) 1997-02-11 2002-07-25 Microgranules containing cisplatin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9701545A FR2759293B1 (fr) 1997-02-11 1997-02-11 Microgranules contenant du cisplatine, procede de fabrication, preparation pharmaceutique et utilisation en polychimiotherapie ou en association avec une radiotherapie

Publications (2)

Publication Number Publication Date
FR2759293A1 FR2759293A1 (fr) 1998-08-14
FR2759293B1 true FR2759293B1 (fr) 1999-04-30

Family

ID=9503556

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9701545A Expired - Lifetime FR2759293B1 (fr) 1997-02-11 1997-02-11 Microgranules contenant du cisplatine, procede de fabrication, preparation pharmaceutique et utilisation en polychimiotherapie ou en association avec une radiotherapie

Country Status (24)

Country Link
US (2) US6458389B1 (enExample)
EP (1) EP0971702B1 (enExample)
JP (1) JP4549445B2 (enExample)
KR (1) KR100471672B1 (enExample)
AR (1) AR011133A1 (enExample)
AT (1) ATE255409T1 (enExample)
BG (1) BG64247B1 (enExample)
BR (1) BR9807319A (enExample)
CA (1) CA2282082C (enExample)
DE (1) DE69820239T2 (enExample)
DK (1) DK0971702T3 (enExample)
EA (1) EA001760B1 (enExample)
ES (1) ES2210726T3 (enExample)
FR (1) FR2759293B1 (enExample)
HU (1) HU225425B1 (enExample)
IL (1) IL131326A (enExample)
IN (1) IN187998B (enExample)
NO (1) NO323230B1 (enExample)
NZ (1) NZ337216A (enExample)
PL (1) PL191631B1 (enExample)
PT (1) PT971702E (enExample)
TW (1) TW561055B (enExample)
WO (1) WO1998034599A1 (enExample)
ZA (1) ZA981123B (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050096304A1 (en) * 1998-09-08 2005-05-05 David White Method of treating cancer using dithiocarbamate derivatives
FR2790668B1 (fr) * 1999-03-12 2002-07-26 D B F Granules contenant une substance vegetale et leur procede de preparation
CN1164262C (zh) * 1999-05-17 2004-09-01 D.B.F.公司 含有植物物质的颗粒及其制备方法
JP5171038B2 (ja) * 2003-10-10 2013-03-27 エティファルム イチョウ・エキスを含む放出持続性の微小顆粒およびそのような顆粒の製造方法
FR2861990B1 (fr) * 2003-11-10 2006-02-10 Nouveaux Produits Pharma Comprimes faiblement doses a reseau de polymeres
MX2007005763A (es) * 2004-11-18 2007-07-20 Squibb Bristol Myers Co Perla recubierta enterica que comprende ixabepilona, y preparacion y administracion de la misma.
EP1832293A4 (en) * 2004-12-10 2009-01-07 Tmrc Co Ltd MEANS FOR THE TREATMENT OF CANCER METASTAS AND CANNESMAS TREATMENT
US9107824B2 (en) 2005-11-08 2015-08-18 Insmed Incorporated Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
FR2918566B1 (fr) * 2007-07-11 2009-10-09 Pierre Fabre Medicament Sa Composition pharmaceutique stable d'un sel hydrosoluble de vinflunine.
FR2918567B1 (fr) * 2007-07-11 2012-08-03 Pf Medicament Composition pharmaceutique stable d'un sel hydrosoluble de vinorelbine.
MX2010003032A (es) * 2007-09-21 2010-04-09 Evonik R Hm Gmbh Composicion farmaceutica opioide de liberacion controlada ph dependiente con resistencia contra la influencia del etanol.
PL2187875T3 (pl) * 2007-09-21 2013-01-31 Evonik Roehm Gmbh Kompozycja farmaceutyczna o zależnym od pH kontrolowanym uwalnianiu dla nieopioidów z odpornością przed wpływem etanolu
US9237760B2 (en) * 2008-01-10 2016-01-19 Evonik Röhm Gmbh Coated pharmaceutical or nutraceutical preparation with enhanced active substance release in the colon
JP2011509266A (ja) * 2008-01-10 2011-03-24 エボニック レーム ゲゼルシャフト ミット ベシュレンクテル ハフツング 活性物質の制御放出が促進された、コーティングされた医薬製剤もしくはニュートラシューティカル製剤
DK177529B1 (en) * 2009-10-23 2013-09-08 Bio Bedst Aps Liposomes with improved storage stability
CA2688202C (en) * 2009-12-11 2012-11-13 Bj Services Company Viscoelastic fluids containing hydroxyethyl cellulose
EP2371356B1 (en) * 2010-03-12 2012-12-19 Phoeme GmbH Multi-particle pharmaceutical formulation for colon absorption
US8070047B1 (en) * 2010-12-02 2011-12-06 Rohm And Haas Electronic Materials Llc Flux composition and method of soldering
PL2892524T3 (pl) 2012-09-04 2021-10-25 Eleison Pharmaceuticals, Llc Zapobieganie nawrotom płucnym przy użyciu cisplatyny w kompleksie z lipidami
JP6487534B2 (ja) 2014-09-05 2019-03-20 シンビオミックス セラピューティクス、エルエルシー 細菌性膣炎の治療に使用するためのセクニダゾール
US10238688B2 (en) * 2015-04-24 2019-03-26 Genedia Biotech Co., Ltd. Combination therapies for bladder cancer
US11253501B2 (en) 2015-06-01 2022-02-22 Lupin Inc. Secnidazole formulations and use in treating bacterial vaginosis
EP3307239B1 (en) 2015-06-12 2020-09-16 Vaxart, Inc. Formulations for small intestinal delivery of rsv and norovirus antigens
TWI795462B (zh) 2017-11-17 2023-03-11 日商鹽野義製藥股份有限公司 光安定性及溶出性優異的醫藥製劑
MX395463B (es) * 2018-04-24 2025-03-25 Shionogi & Co Forma de dosificacion solida que tiene excelente estabilidad
KR102501180B1 (ko) 2018-04-24 2023-02-21 시오노기세야쿠 가부시키가이샤 안정성이 우수한 고형 제제
US12280037B2 (en) 2020-09-22 2025-04-22 Evofem Biosciences, Inc. Method and pharmaceutical composition for treating or preventing trichomoniasis and uses thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE15971T1 (de) * 1981-03-11 1985-10-15 Mirko Beljanski Serpentin, alstonin und sempervirin, medikamente, die die tumor- und krebszellen spezifisch hemmen.
IT1153974B (it) * 1982-09-23 1987-01-21 Erba Farmitalia Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento
DE3421468A1 (de) * 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
DE3523454A1 (de) * 1985-07-01 1987-01-08 Eberhard Prof Dr Nuernberg Formkoerper
US4925674A (en) * 1988-08-25 1990-05-15 Himedics, Inc. Amoxicillin microencapsulated granules
US5399363A (en) * 1991-01-25 1995-03-21 Eastman Kodak Company Surface modified anticancer nanoparticles
JPH05294839A (ja) * 1992-04-20 1993-11-09 Biomaterial Universe Kk シスプラチン含有生体内分解吸収性高分子の微小球お よびその製造法
US5795882A (en) * 1992-06-22 1998-08-18 Bone Care International, Inc. Method of treating prostatic diseases using delayed and/or sustained release vitamin D formulations
JPH07112932A (ja) * 1993-08-27 1995-05-02 Mitsui Toatsu Chem Inc 徐放性医薬製剤
JPH0789849A (ja) * 1993-09-20 1995-04-04 Fujisawa Pharmaceut Co Ltd 徐放性製剤
JPH0859460A (ja) * 1994-08-22 1996-03-05 Tanaka Kikinzoku Kogyo Kk 抗ガン剤内包キトサンミクロスフェア及びその製造法
US5637319A (en) * 1995-03-01 1997-06-10 Takada; Kanji Controlled-release preparations
US5614206A (en) * 1995-03-07 1997-03-25 Wright Medical Technology, Inc. Controlled dissolution pellet containing calcium sulfate
DE69725747T2 (de) * 1996-08-23 2004-07-29 Sequus Pharmaceuticals, Inc., Menlo Park Liposome enthaltend cisplatin

Also Published As

Publication number Publication date
NZ337216A (en) 2000-09-29
NO993881D0 (no) 1999-08-11
JP2001512433A (ja) 2001-08-21
DK0971702T3 (da) 2004-04-13
TW561055B (en) 2003-11-11
KR100471672B1 (ko) 2005-03-07
JP4549445B2 (ja) 2010-09-22
AR011133A1 (es) 2000-08-02
PL335107A1 (en) 2000-04-10
AU744001B2 (en) 2002-02-14
WO1998034599A1 (fr) 1998-08-13
DE69820239T2 (de) 2004-10-07
HUP0001719A3 (en) 2005-11-28
IL131326A (en) 2005-03-20
US6458389B1 (en) 2002-10-01
HUP0001719A2 (hu) 2000-11-28
BG64247B1 (bg) 2004-07-30
BG103647A (en) 2000-03-31
IN187998B (enExample) 2002-08-03
ATE255409T1 (de) 2003-12-15
EP0971702A1 (fr) 2000-01-19
NO993881L (no) 1999-09-29
AU6626798A (en) 1998-08-26
EP0971702B1 (fr) 2003-12-03
CA2282082C (fr) 2005-10-18
PL191631B1 (pl) 2006-06-30
ES2210726T3 (es) 2004-07-01
HU225425B1 (en) 2006-11-28
EA199900734A1 (ru) 2000-04-24
ZA981123B (en) 1998-08-20
CA2282082A1 (fr) 1998-08-13
BR9807319A (pt) 2000-04-18
IL131326A0 (en) 2001-01-28
FR2759293A1 (fr) 1998-08-14
US20030017210A1 (en) 2003-01-23
KR20000070997A (ko) 2000-11-25
NO323230B1 (no) 2007-02-05
EA001760B1 (ru) 2001-08-27
DE69820239D1 (de) 2004-01-15
PT971702E (pt) 2004-04-30

Similar Documents

Publication Publication Date Title
DE68920223D1 (de) Enzymelektroden und ihre Herstellung.
BR0007065B1 (pt) sistema e método de processamento de sangue e método de processamento de glóbulos vermelhos.
AU1610495A (en) Monitoring water treatment agent in-system concentration and regulating dosage
ITRM950485A0 (it) Traspiratore di insetticida azionato a batteria e metodo per far traspirare l'insetticida.
FI971749A0 (fi) Lipolyyttistä aktiivisuutta omaava entsyymi
DE68907088D1 (de) Streifenfoermiges verstaerkungslaminat und luftreifen.
FI950228A0 (fi) Puhelun uudelleenmuodostaminen yhteyden katkeamisen jälkeen
TR199600253A1 (tr) Karisik plastiklerin tekrar islenmesi islemi ve tertibati.
HUT77075A (hu) Hatóanyagok és alkalmazásuk
DE69018547D1 (de) Anzeigevorrichtungen mit aktiver Matrix und ihre Herstellungsverfahren.
DE69531376D1 (de) System zur Herzreizung im VDD(R)-Modus
EE9900477A (et) Ühendid ja kompositsioonid seriinproteaasse, eriti trüptaasse aktiivsusega seotud haiguste raviks
TR199801871A3 (tr) Bifenilsulfonilsiyanamidler üretim yöntemi ve ilaç olarak kullanimlari.
DE3860711D1 (de) Mittel gegen protozoen bei insekten.
FR2774910B1 (fr) Microgranules de sulfate de morphine, procede de fabrication et preparations pharmaceutiques
DE59608280D1 (de) Schadpilzbekämpfung mit der kombination eines die atmung am cytochrom-komplex iii hemmenden wirkstoffes mit fenazaquin
FI941912A0 (fi) 3-kinolyylillä substituoidut dihydropyridiinit, menetelmä niiden valmistamiseksi ja niiden käyttö lääkeaineissa
NO900088D0 (no) Fremgangsmaate ved bestemmelse av den fibrinolytiske totalaktivitet i plasma.
DE3586952D1 (de) Fibrinophiler urokinase-komplex und dessen herstellung.
TR199501627A2 (tr) Tepkime alanlari farkli verimlere sahip olmak üzere, üre üretimi icin yöntem ve donanim.
FR2733418B1 (fr) Nouvelles associations comprenant du (-) hydroxycitrate et presentant notamment de nouvelles activites therapeutiques
ID26292A (id) TURUNAN-TURUNAN BARU ASAM OKTAHIDRO-6,10-DIOKSO-6H-PIRIDAZINO [1,2-a] 1,2]DIAZEPINA-1-KARBOKSILAT, PROSES PEMBUATANNYA DAN PENGGUNANNYA DALAM PEMBUATAN SENYAWA-SENYAWA AKTIF SECARA TERAPETIK
EP0742009A3 (de) Gegen Bakterien, Mycota und Viren wirksame Substanzen
EP1198603A4 (en) AUTOMATIC STEEL WITH TIN, ANTIMON AND / OR ARSEN
TR199700109A2 (tr) Sübstitüe edilmis olan tiofenilalkenil karbonik asit guanidid'leri, bunlarin üretilmesine mahsus usul, bunlarin ilac veya diyagnostik olarak kullanilmalari ve bunlari iceren ilac.

Legal Events

Date Code Title Description
GC Lien (pledge) constituted
GC Lien (pledge) constituted

Effective date: 20140519

PLFP Fee payment

Year of fee payment: 20

GC Lien (pledge) constituted

Effective date: 20160120

RG Lien (pledge) cancelled

Effective date: 20160226

RG Lien (pledge) cancelled

Effective date: 20170418